Sort
30,917 grants matching “tumor microenvironment”
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
$661,842Shrikant Anant · University Of Kansas Medical Center · R01 · FY2018 · CA
Therapeutic targeting MDSC-mediated immune suppression in cancer
$661,690Yulia Nefedova · Wistar Institute · R01 · FY2024 · CA
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma
$661,609Hsian-Rong Tseng · Eximius Diagnostics Corp · R44 · FY2024 · CA
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma
$661,609Hsian-Rong Tseng · Eximius Diagnostics Corp · R44 · FY2025 · CA
Developing and Automating an Extracellular Vesicle-Based Test for Early Detection of Hepatocellular Carcinoma
$661,609Hsian-Rong Tseng · Eximius Diagnostics Corp · R44 · FY2023 · CA
Tumor and immune determinants of effective anti-tumor immunity in renal cell carcinoma
$661,522David Braun · Yale University · R37 · FY2025 · CA
Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles
$661,505Yazhen Zhu · University Of California Los Angeles · R01 · FY2025 · CA
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
$661,394Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$661,391Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA
Combined Imaging and RNA Analyses to Develop Cervical Cancer Biomarkers
$661,302Hua Li · Washington University · R01 · FY2024 · CA
New tools for quantitative non-invasive recording of biochemical signals
$661,301Nathan Christopher Shaner · University Of California, San Diego · R01 · FY2025 · CA
Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells
$661,289Wendell A Lim · University Of California, San Francisco · R01 · FY2017 · CA
Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells
$661,149Wendell A Lim · University Of California, San Francisco · R01 · FY2016 · CA
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell Lung Cancer
$661,095Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · U01 · FY2021 · CA
Develop a novel therapy with immuno- and onco-targeting dual efficacies to treat the triple negative breast cancer
$661,072Deyu Fang · Northwestern University At Chicago · R01 · FY2025 · CA
Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
$661,067Kwok Kin Wong · New York University School Of Medicine · U01 · FY2018 · CA
Optimizing anti-wild-type IDH1 therapy in pancreatic cancer
$661,060Jordan M Winter · Case Western Reserve University · R01 · FY2025 · CA
Deep molecular and cellular profiling of colorectal cancer tumor and immune microenvironment in Alaska Native people
$661,051Jeroen R Huyghe · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer
$661,043Andrew Sikora · University Of Tx Md Anderson Can Ctr · U01 · FY2022 · DE
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
$661,011Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Tumor Microenvironment in Cancer Progression
$661,011Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Interplay of natural killer cells and extracellular matrix proteins in solid cancers
$660,987Shadmehr Demehri · Massachusetts General Hospital · R01 · FY2024 · CA
Interplay of natural killer cells and extracellular matrix proteins in solid cancers
$660,987Shadmehr Demehri · Massachusetts General Hospital · R01 · FY2025 · CA
Targeting the Mitochondria to Overcome Resistance to Immune Checkpoint Inhibition in Malignant Pleural Mesothelioma
$660,954Robert Taylor Ripley · Baylor College Of Medicine · R37 · FY2024 · CA
DNA-based Immune Phenotyping in HNSCC for Biomarkers of Response to Immunotherapy
$660,888Karl T Kelsey · Brown University · R01 · FY2025 · CA